S. 2426 119th Congress
Equitable Community Access to Pharmacist Services Act
Latest action, Jul 24, 2025: Read twice and referred to the Committee on Finance. (text: CR S4701)
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
33 cosponsors
Sponsored by John Thune (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
17 D · 16 R
- Democrat
- Republican
- Independent
Referred to: Senate: Finance Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
5 reports
AMERICAN MEDICAL ASSOCIATION
AVENUE SOLUTIONS
5 reports
5 reports
5 reports
5 reports
5 reports
MCKESSON CORPORATION
KOUNTOUPES DENHAM CARR & REID, LLC
5 reports
5 reports
CENCORA, INC.
BALLARD SPAHR LLP
4 reports
4 reports
4 reports
All 25 of 38 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION | 5 | $4.8M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN MEDICAL ASSOCIATION | 5 | $27.7M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN MEDICAL ASSOCIATION | AVENUE SOLUTIONS | 5 | $0 | Q4 2025 | Q3 2026 | yes |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 5 | $1.2M | Q4 2025 | Q3 2026 | yes | |
| CARDINAL HEALTH INC | 5 | $3.3M | Q4 2025 | Q3 2026 | yes | |
| CENCORA, INC. | 5 | $4.7M | Q4 2025 | Q3 2026 | yes | |
| CVS HEALTH (AND SUBSIDIARIES) | 5 | $13.3M | Q4 2025 | Q3 2026 | yes | |
| FOOD MARKETPLACE INC | 5 | $2.4M | Q4 2025 | Q3 2026 | yes | |
| MCKESSON CORPORATION | KOUNTOUPES DENHAM CARR & REID, LLC | 5 | $300K | Q4 2025 | Q3 2026 | yes |
| NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 5 | $1.5M | Q4 2025 | Q3 2026 | yes | |
| WALMART INC | 5 | $10.5M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN COLLEGE OF EMERGENCY PHYSICIANS | 4 | $1.9M | Q4 2025 | Q3 2026 | yes | |
| CENCORA, INC. | BALLARD SPAHR LLP | 4 | $0 | Q4 2025 | Q3 2026 | yes |
| HEALTHCARE LEADERSHIP COUNCIL | 4 | $750K | Q3 2025 | Q3 2026 | yes | |
| INDEPENDENT PHARMACY COOPERATIVE | 4 | $170K | Q4 2025 | Q3 2026 | yes | |
| NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 4 | $1.4M | Q3 2025 | Q3 2026 | yes | |
| SUTTER HEALTH | VENABLE LLP | 4 | $320K | Q4 2025 | Q3 2026 | yes |
| AMERICAN PHARMACIES, INC. | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 3 | $180K | Q4 2025 | Q1 2026 | yes |
| INDEPENDENT PHARMACY COOPERATIVE | FORBES-TATE | 3 | $0 | Q1 2026 | Q3 2026 | yes |
| KROGER CO | 3 | $1.1M | Q1 2026 | Q3 2026 | yes | |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 3 | $9.5M | Q1 2026 | Q3 2026 | yes | |
| SURESCRIPTS | MCDERMOTT WILL & SCHULTE LLP | 3 | $90K | Q1 2026 | Q3 2026 | yes |
| ABBOTT LABORATORIES | 2 | $2.0M | Q4 2025 | Q2 2026 | yes | |
| ABBOTT LABORATORIES | KOUNTOUPES DENHAM CARR & REID, LLC | 2 | $0 | Q4 2025 | Q3 2025 | yes |
| ACADEMY OF MANAGED CARE PHARMACY | TIBER CREEK GROUP | 2 | $80K | Q2 2026 | Q3 2026 | yes |